Bank of New York Mellon’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bank of New York Mellon’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8,327	Closed	-$642K	–	4428
2021 Q1	$642K	Buy	8,327 +541	+7%	+$49.8K	﹤0.01%	3556
2020 Q4	$771K	Sell	7,786 -1,513	-16%	-$185K	﹤0.01%	3396
2020 Q3	$1.32M	Buy	9,299 +1,259	+16%	+$210K	﹤0.01%	2944
2020 Q2	$1.59M	Buy	8,040 +5,047	+169%	+$1.05M	﹤0.01%	2815
2020 Q1	$586K	Buy	2,993 +261	+10%	+$56.2K	﹤0.01%	3276
2019 Q4	$566K	Sell	2,732 -72,266	-96%	-$13.4M	﹤0.01%	3535
2019 Q3	$11.4M	Sell	74,998 -171,129	-70%	-$28M	﹤0.01%	1853
2019 Q2	$31.7M	Sell	246,127 -13,575	-5%	-$1.61M	0.01%	1260
2019 Q1	$30.6M	Buy	259,702 +10,565	+4%	+$1.07M	0.01%	1285
2018 Q4	$22.9M	Buy	249,137 +209,642	+531%	+$21.3M	0.01%	1384
2018 Q3	$4.44M	Sell	39,495 -155	-0.4%	-$16.4K	﹤0.01%	2462
2018 Q2	$3.65M	Buy	39,650 +41	+0.1%	+$3.98K	﹤0.01%	2543
2018 Q1	$3.95M	Buy	39,609 +163	+0.4%	+$17.6K	﹤0.01%	2470
2017 Q4	$3.7M	Sell	39,446 -1,367	-3%	-$129K	﹤0.01%	2496
2017 Q3	$4.15M	Buy	40,813 +2,720	+7%	+$238K	﹤0.01%	2429
2017 Q2	$2.92M	Buy	38,093 +173	+0.5%	+$14.6K	﹤0.01%	2617
2017 Q1	$3.27M	Sell	37,920 -24,501	-39%	-$1.76M	﹤0.01%	2556
2016 Q4	$4.01M	Sell	62,421 -666	-1%	-$41K	﹤0.01%	2446
2016 Q3	$4.08M	Sell	63,087 -2,414	-4%	-$136K	﹤0.01%	2340
2016 Q2	$3.63M	Buy	+65,501	New	+$3.29M	﹤0.01%	2379

Other funds holding LKFT

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Bank of New York Mellon's LKFT Position: Q2 2021 in Review

Bank of New York Mellon sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2021, closing a stake of 8,327 shares — an estimated $642K sold.

Bank of New York Mellon first reported a position in LKFT in Q2 2016 and held it in 20 quarters. The position peaked at $31.7M in Q2 2019. 108 funds tracked by Wall St. Rank hold LKFT as of Q2 2021.

Bank of New York Mellon reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Bank of New York Mellon sold 8,327 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2021, an estimated $642K.
Bank of New York Mellon first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2016 and held it in 20 quarters.
Bank of New York Mellon's Lakefront Biotherapeutics American Depositary Shares position peaked at $31.7M in Q2 2019.
108 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2021.

Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.